Both in Pharmaceuticals
Olema Pharmaceuticals vs Design Therapeutics
Over the past year OLMA returned −12.7% and DSGN returned +57.9%; their daily moves had a correlation of 0.21.
OLMA −12.7% DSGN +57.9%Growth of $1, one year, split-adjusted
| Metric | OLMA | DSGN |
|---|---|---|
| Price | $7.35 | $10.34 |
| Market cap | $643.1M | $647.1M |
| Today | +3.96% | +1.87% |
| 1 month | −10.9% | −16.7% |
| 6 months | −49.8% | −22.9% |
| Year to date | −70.6% | +10.2% |
| 1 year | −18.1% | +54.3% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $458.1M | $207.4M |
| Dividend yield | — | — |
| Volatility (60d) | 60.6% | 55.2% |
| Short % of float | 24.8% | 21.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).